Evexia Lifecare is a diversified healthcare company spanning pharmaceutical chemical trading, pharmacy services, diagnostics, and personal healthcare.
evexialifecare.comCrawled Nov 13, 2026
Evexia Lifecare Limited reported earnings results for the second quarter and six months ended September 30, 2026. For the second quarter, the company reported sales was INR 250.18 million compared to INR 257.27 million a year ago. Revenue was INR 258.16 million compared to INR 261.61 million a year ago. Net income was INR 2.31 million compared to INR 3.72 million a year ago. Basic earnings per share from continuing operations was INR 0.001 compared to INR 0.002 a year ago. Diluted earnings per s
Oct 2026MarketScreenerNews article
The December 2025 quarter results paint a concerning picture of margin compression and profitability challenges. While net sales reached ₹25.24 crores—a modest 16.31% improvement year-on-year—the company witnessed a sequential revenue decline of 1.90% from the previous quarter's ₹25.73 crores. More troubling is the sharp deterioration in profitability metrics, with operating profit margin excluding other income collapsing to just 0.99% from 4.84% in Q2 FY26, signalling significant operational st
Feb 2026Markets MojoNews article
The Evexia Lifecare share price climbed 3.44% to ₹1.80 on November 17, marking the second consecutive session of gains. This surge comes amid heightened trading activity, reflecting renewed market interest in the penny stock.
Nov 2025Samco SecuritiesNews article
MUMBAI: Gujarat-based Evexia Lifecare, a prominent player in the fast-moving consumer goods (FMCG) sector, is embarking on a significant global expansion through the acquisition of a 51 per cent stake in Vittal's MediCare Private Limited, a diagnostics company located in the UAE.
Oct 2024Business Benchmark NewsNews article